BEROSONULIM Trademark

Trademark Overview

On Thursday, July 3, 2014, a trademark application was filed for BEROSONULIM with the United States Patent and Trademark Office. The USPTO has given the BEROSONULIM trademark a serial number of 86328711. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 15, 2024. This trademark is owned by Health Ever Bio-Tech Co., Ltd.. The BEROSONULIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating prostate diseases, cardiovascular diseases, bone diseases, and for cancer treatment and prevention
berosonulim

General Information

Serial Number86328711
Word MarkBEROSONULIM
Filing DateThursday, July 3, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 15, 2024
Registration Number5281565
Registration DateTuesday, September 5, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating prostate diseases, cardiovascular diseases, bone diseases, and for cancer treatment and prevention

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 15, 2024
Primary Code005
First Use Anywhere DateThursday, June 15, 2017
First Use In Commerce DateThursday, June 15, 2017

Trademark Owner History

Party NameHealth Ever Bio-Tech Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTaipei
TW
Party NameHealth Ever Bio-Tech Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTaipei
TW
Party NameHealth Ever Bio-Tech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei
TW

Trademark Events

Event DateEvent Description
Friday, March 15, 2024CANCELLED SEC. 8 (6-YR)
Monday, September 5, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 5, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, August 2, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 1, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 13, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 12, 2017USE AMENDMENT FILED
Wednesday, July 12, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 16, 2016SOU EXTENSION 4 GRANTED
Friday, December 16, 2016SOU EXTENSION 4 FILED
Friday, December 16, 2016SOU TEAS EXTENSION RECEIVED
Thursday, July 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 20, 2016SOU EXTENSION 3 GRANTED
Wednesday, July 6, 2016SOU EXTENSION 3 FILED
Wednesday, July 6, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, February 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 16, 2016SOU EXTENSION 2 GRANTED
Thursday, January 7, 2016SOU EXTENSION 2 FILED
Friday, February 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 7, 2016SOU TEAS EXTENSION RECEIVED
Saturday, February 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 19, 2015SOU EXTENSION 1 GRANTED
Thursday, February 19, 2015SOU EXTENSION 1 FILED
Thursday, February 19, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, January 13, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 18, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 14, 2014ASSIGNED TO EXAMINER
Thursday, July 10, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 7, 2014NEW APPLICATION ENTERED

Related Keywords

berosonulim diseases cancer treatment prevention bone cardiovascular treating prostate pharmaceutical preparations